CM Life Sciences Inc. (CMLF)
NASDAQ: CMLF
· Real-Time Price · USD
11.60
-0.88 (-7.05%)
At close: Jul 23, 2021, 6:00 AM
Company Description
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses.
The company was founded in 2020 and is based in New York, New York.
CM Life Sciences Inc.
| Country | United States |
| IPO Date | Oct 26, 2020 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Eli Decatur Casdin |
Contact Details
Address: 667 Madison Avenue New York City, New York United States | |
| Website | http://i.cmlifesciencesspac.com |
Stock Details
| Ticker Symbol | CMLF |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001818331 |
| CUSIP Number | |
| ISIN Number | US18978W1099 |
| Employer ID | 85-1966622 |
| SIC Code | 8000 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Aug 07, 2025 | 4/A | [Amend] Filing |
| Aug 06, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jul 31, 2025 | 4 | Filing |
| Jul 31, 2025 | 4 | Filing |
| Jul 30, 2025 | SCHEDULE 13G | Filing |
| Jul 29, 2025 | 10-Q | Quarterly Report |
| Jul 29, 2025 | 8-K | Current Report |
| Jul 11, 2025 | 4 | Filing |
| Jul 11, 2025 | 4 | Filing |